DYAI
Companies
NASDAQ
Dyadic International Inc.
Health Care
$0.99
-$0.76 (-43.43%)
Price Chart
Overview
About DYAI
dyadic international, inc. (otcqx: dyai) - we are a global biotechnology company focused on further improving and leveraging the patented and proprietary c1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.
Market Cap
$59.1M
Volume
41.9K
Avg. Volume
50.3K
P/E Ratio
-3.8437502
Dividend Yield
0.00%
Employees
27.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.89
Moderate Correlation
Volatility
High (0.87)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, DYAI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$59.1M
Volume41.9K
P/E Ratio-3.84
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 27, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025